Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$8,995,123
+$836,639 QoQ
Shares Held
35,746
-4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#979
of 4,152 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $71,369,097 across 13 Drug Manufacturers - General names. ABBV ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,725 | $27,257,049 | |
| 2 | JNJ |
Johnson & Johnson
|
60,120 | $15,268,676 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
35,746 | $8,995,123 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,212 | $5,552,742 | |
| 5 | PFE |
Pfizer Inc
|
185,560 | $4,468,284 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
51,332 | $2,957,749 | |
| 7 | AMGN |
Amgen Inc
|
6,773 | $2,452,638 | |
| 8 | NVS |
Novartis AG
|
8,976 | $1,406,718 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,995,123 | 35,746 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $8,158,484 | 37,512 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $8,567,004 | 37,494 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $8,639,220 | 37,312 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $6,954,438 | 37,466 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $7,904,980 | 37,729 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $6,879,655 | 38,715 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $7,445,785 | 37,704 | Shares | Defined | 2024-10-24 | |
| 2024-03-31 | $5,476,475 | 30,074 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $4,455,077 | 28,748 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,281,897 | 28,726 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,848,562 | 28,565 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,053,463 | 31,709 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,127,604 | 37,916 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,109,911 | 38,074 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,503,191 | 35,931 | Shares | Sole | 2022-08-01 | |
| 2021-12-31 | $4,789,639 | 35,374 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,198,408 | 38,921 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,035,873 | 26,952 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $2,916,745 | 26,952 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,996,021 | 27,961 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,301,952 | 26,281 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,507,026 | 25,535 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,963,035 | 25,765 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||